2014 APASL College
BACK | EN | 中文
Campaign Details
Current situation
There is a high incidence of hepatitis B in China. According to the ministry of health statistics ,that there have hepatitis B over ten thousand 277 in China, is more than United States 40 times with annual incidence of over ten thousand 95. In legal infectious disease, its incidence is second only to infectious diarrhea with influenza in third place. Asia Pacific Association for the study of the liver (APASL) has been engaged in the study of liver diseases in terms of academic, organize the doctor education meeting every year, improve the level of treatment, the benefit of patients.
Goal
APASL College is APASL promote to cultivate intermediate and senior physician in the new technology and new strategies by a training plan, with the form in English in-depth discussion and communication.Cover the physician in hepatitis so much, development of the hepatitis treatment.
The Strategy
The conference have a award for young investigator in Beijing and Guangzhou, a total of 10 doctors in this competition, they make the wonderful English speech in the conference.The winners obtain to go to 2014 AASLD and 2015 APASL meeting for free.
Execution
Guangzhou Nanfang Hospital and Beijing university people's hospital were provided in the venue, to create an atmosphere of school. The room layout is also highlighted the characteristics of campus. The conference have a award for young investigator in Beijing and Guangzhou, a total of 10 doctors in this competition.All of the 10 doctors through abstract in early. And the winners receive the elaborate crystal certificate.
Results
The meeting was very successful, there are more than 150 doctors join the conference in Beijing and Guangzhou. They got the experience and new progress in disease treatment from the experts in hepatitis from China and abroad. And also they got the chance of a close communication with experts to meet, especially the young investigator.APASL College will be held in different cities every year in the future.